Guangzhou Xiangxue Pharmaceutical Co.,Ltd. Posted 273.9 Million Yuan Net Loss in First Three Quarters of 2022

Guangzhou Xiangxue Pharmaceutical Co.,Ltd. (广州市香雪制药股份有限公司) (300147.SZ) reported a net loss of 273.9 million yuan in the first three quarters of 2022, reversing a net profit of 47.7 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.7 billion yuan in revenue, down 21.9% year-on-year.

At the end of the reporting period, it had 9.3 billion yuan in total assets and 6.3 billion yuan in total liabilities, with a liability-to-asset ratio of 67%.